J A Verhelst

Summary

Affiliation: Middelheim Hospital
Country: Belgium

Publications

  1. ncbi Workshop A: management of endocrine disorders during pregnancy
    J A Verhelst
    AZ Middelheim, Department of Endocrinology, Lindendreef 1, 2020, Antwerp, Belgium
    Growth Horm IGF Res 13:S33. 2003
  2. ncbi Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients
    J Verhelst
    Department of Endocrinology, Middelheim Ziekenhuis, Antwerpen, Belgium
    J Clin Endocrinol Metab 84:2518-22. 1999
  3. ncbi Hyperprolactinemia: pathophysiology and management
    Johan Verhelst
    Department of Endocrinology, Middelheim Hospital, Antwerp, Belgium
    Treat Endocrinol 2:23-32. 2003
  4. ncbi Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients
    J A Verhelst
    Department of Endocrinology, Middelheim Ziekenhuis Antwerpen, Belgium
    Eur J Endocrinol 143:577-84. 2000
  5. ncbi Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer
    Johan Verhelst
    General Hospital Middleheim, Antwerp, Belgium
    J Clin Endocrinol Metab 90:4636-43. 2005
  6. ncbi Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database
    Roger Abs
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Growth Horm IGF Res 15:349-59. 2005
  7. ncbi Modification of hormonal secretion in clinically silent pituitary adenomas
    Tania Daems
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium
    Pituitary 12:80-6. 2009
  8. ncbi The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma
    Pat Kendall-Taylor
    University of Newcastle, UK
    Eur J Endocrinol 152:557-67. 2005

Collaborators

Detail Information

Publications8

  1. ncbi Workshop A: management of endocrine disorders during pregnancy
    J A Verhelst
    AZ Middelheim, Department of Endocrinology, Lindendreef 1, 2020, Antwerp, Belgium
    Growth Horm IGF Res 13:S33. 2003
  2. ncbi Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients
    J Verhelst
    Department of Endocrinology, Middelheim Ziekenhuis, Antwerpen, Belgium
    J Clin Endocrinol Metab 84:2518-22. 1999
    ..Once PRL secretion was adequately controlled, the dose of cabergoline could often be significantly decreased, which further reduced costs of therapy...
  3. ncbi Hyperprolactinemia: pathophysiology and management
    Johan Verhelst
    Department of Endocrinology, Middelheim Hospital, Antwerp, Belgium
    Treat Endocrinol 2:23-32. 2003
    ..In the small group of patients who do not respond to this treatment, or who refuse long-term therapy, surgery is offered. Radiotherapy is given if both pharmacologic therapy and surgery fail...
  4. ncbi Slow-release lanreotide in the treatment of acromegaly: a study in 66 patients
    J A Verhelst
    Department of Endocrinology, Middelheim Ziekenhuis Antwerpen, Belgium
    Eur J Endocrinol 143:577-84. 2000
    ..Lanreotide SR has been found to be well tolerated and effective in reducing GH and IGF-I levels but clinical data are still limited compared with those with subcutaneous octreotide treatment...
  5. ncbi Baseline characteristics and response to 2 years of growth hormone (GH) replacement of hypopituitary patients with GH deficiency due to adult-onset craniopharyngioma in comparison with patients with nonfunctioning pituitary adenoma: data from KIMS (Pfizer
    Johan Verhelst
    General Hospital Middleheim, Antwerp, Belgium
    J Clin Endocrinol Metab 90:4636-43. 2005
    ..To analyze this difference, we used the KIMS database (Pfizer International Metabolic Database) comparing CP and NFPA patients in terms of baseline characteristics and responses to GH replacement...
  6. ncbi Isolated growth hormone (GH) deficiency in adult patients: baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database
    Roger Abs
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, B 2650 Edegem, Belgium
    Growth Horm IGF Res 15:349-59. 2005
    ....
  7. ncbi Modification of hormonal secretion in clinically silent pituitary adenomas
    Tania Daems
    Department of Endocrinology, University Hospital Antwerp, Wilrijkstraat 10, Edegem 2650, Belgium
    Pituitary 12:80-6. 2009
    ..Silent corticotroph adenomas are the classical example of this phenomenon...
  8. ncbi The clinical, metabolic and endocrine features and the quality of life in adults with childhood-onset craniopharyngioma compared with adult-onset craniopharyngioma
    Pat Kendall-Taylor
    University of Newcastle, UK
    Eur J Endocrinol 152:557-67. 2005
    ..Craniopharyngioma is a parasellar tumour that, although benign, tends to behave aggressively. It can occur at any age but most commonly presents in childhood or adolescence...